• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-139-5p 通过靶向 ATAD2 抑制非小细胞肺癌进展。

MicroRNA-139-5p suppresses non-small cell lung cancer progression by targeting ATAD2.

机构信息

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, PR China.

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, PR China.

出版信息

Pathol Res Pract. 2023 Sep;249:154719. doi: 10.1016/j.prp.2023.154719. Epub 2023 Jul 26.

DOI:10.1016/j.prp.2023.154719
PMID:37595446
Abstract

MiR-139-5p is a suppressor in multiple types of cancer. However, whether miR-139-5p affects NSCLC is unknown. In this study, miR-139-5p expression in clinical samples was examined by real-time PCR and in situ hybridization (ISH). MiR-139-5p mimic was transfected to monitor NSCLC cell behaviors. Potential target was predicated using bioinformatics database. Next, whether miR-139-5p impacted cell behaviors via regulation of its predicted target gene were further evaluated. The result revealed that miR-139-5p was lower in NSCLC samples/cells. MiR-139-5p restrained A549 cell proliferation, accelerated apoptosis, and inhibited the β-catenin signaling. ATAD2 was a predicted target of miR-139-5p, and it was highly expressed in NSCLC tissues. ATAD2 overexpression abolished the miR-139-5p's anti-tumor effect on cell proliferation and apoptosis. TWS119 (a β-catenin signaling activator) partially reversed miR-139-5p overexpression-induced suppression of cell proliferation and promotion of cell apoptosis. In tumor xenografts, miR-139-5p restrained tumor growth. MiR-139-5p was a tumor suppressor in NSCLC by regulating the oncogene ATAD2 and β-catenin signaling. Our study provides a promising target for cancer treatment.

摘要

miR-139-5p 是多种癌症的抑制因子。然而,miR-139-5p 是否影响 NSCLC 尚不清楚。在本研究中,通过实时 PCR 和原位杂交(ISH)检测临床样本中的 miR-139-5p 表达。转染 miR-139-5p 模拟物以监测 NSCLC 细胞行为。使用生物信息学数据库预测潜在靶标。接下来,进一步评估 miR-139-5p 是否通过调节其预测靶基因来影响细胞行为。结果表明,miR-139-5p 在 NSCLC 样本/细胞中表达降低。miR-139-5p 抑制 A549 细胞增殖,加速细胞凋亡,并抑制 β-catenin 信号。ATAD2 是 miR-139-5p 的预测靶标,在 NSCLC 组织中高表达。ATAD2 过表达消除了 miR-139-5p 对细胞增殖和凋亡的抗肿瘤作用。TWS119(β-catenin 信号激活剂)部分逆转了 miR-139-5p 过表达诱导的细胞增殖抑制和细胞凋亡促进。在肿瘤异种移植中,miR-139-5p 抑制肿瘤生长。miR-139-5p 通过调节癌基因 ATAD2 和 β-catenin 信号在 NSCLC 中起肿瘤抑制作用。我们的研究为癌症治疗提供了一个有前途的靶点。

相似文献

1
MicroRNA-139-5p suppresses non-small cell lung cancer progression by targeting ATAD2.微小 RNA-139-5p 通过靶向 ATAD2 抑制非小细胞肺癌进展。
Pathol Res Pract. 2023 Sep;249:154719. doi: 10.1016/j.prp.2023.154719. Epub 2023 Jul 26.
2
Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.下调 miR-3127-5p 通过 FZD4 调控 Wnt/β-catenin 信号通路促进非小细胞肺癌上皮-间质转化。
Mol Carcinog. 2018 Jul;57(7):842-853. doi: 10.1002/mc.22805. Epub 2018 Apr 14.
3
Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and Invasion.MiR-3619-5p在β-连环蛋白介导的非小细胞肺癌生长和侵袭中的作用
Cell Physiol Biochem. 2015;37(4):1527-36. doi: 10.1159/000438520. Epub 2015 Oct 30.
4
MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.miR-200b-5p 通过靶向 ATAD2 并调节 PI3K/AKT 信号通路抑制卵巢癌细胞的增殖。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9860-9868. doi: 10.26355/eurrev_202010_23196.
5
Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.人参皂苷 Rh2 通过海绵吸附 miR-28-5p/STK4 轴和使 Wnt/β-连环蛋白信号失活来抑制非小细胞肺癌的进展。
Cancer Med. 2023 Jun;12(11):12653-12667. doi: 10.1002/cam4.5960. Epub 2023 Apr 20.
6
Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.长链非编码 RNASEH1-AS1 通过作为 ceRNA 调节 microRNA-516a-5p/FOXK1 并激活 Wnt/β-catenin 信号通路来加剧非小细胞肺癌的进展。
Cancer Med. 2022 Apr;11(7):1589-1604. doi: 10.1002/cam4.4509. Epub 2022 Feb 15.
7
Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.miR-181d-5p 通过 CDKN3 介导的 Akt 信号通路对非小细胞肺癌的体内外抑瘤作用。
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L918-L933. doi: 10.1152/ajplung.00334.2018. Epub 2019 Jan 10.
8
Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.长链非编码 RNA LINC00326 的上调通过调节 miR-657/ Dickkopf WNT 信号通路抑制剂 2 轴来阻断 Wnt/β-连环蛋白通路抑制非小细胞肺癌的进展。
Biol Direct. 2023 Feb 6;18(1):3. doi: 10.1186/s13062-023-00359-9.
9
MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.miRNA-195-5p 通过直接靶向 CIAPIN1 作为非小细胞肺癌的肿瘤抑制因子和不良预后的预测因子。
Pathol Oncol Res. 2019 Jul;25(3):1181-1190. doi: 10.1007/s12253-018-0552-z. Epub 2019 Jan 12.
10
MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.miR-411-5p 通过靶向 PUM1 在非小细胞肺癌中发挥肿瘤抑制作用。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5546-5553. doi: 10.26355/eurrev_201809_15816.

引用本文的文献

1
Exosomal AC068768.1 enhances the proliferation, migration, and invasion of laryngeal squamous cell carcinoma through miR-139-5p/NOTCH1 axis.外泌体AC068768.1通过miR-139-5p/NOTCH1轴增强喉鳞状细胞癌的增殖、迁移和侵袭能力。
Heliyon. 2024 Aug 15;10(16):e36358. doi: 10.1016/j.heliyon.2024.e36358. eCollection 2024 Aug 30.
2
Identification of Hub Genes and Analysis of their Regulatory miRNAs in Patients with Thymoma Associated Myasthenia Gravis Based on TCGA Database.基于TCGA数据库的胸腺瘤伴重症肌无力患者关键基因的鉴定及其调控miRNA的分析
Microrna. 2025;14(1):49-58. doi: 10.2174/0122115366299210240823062457.
3
Circulating microRNAs in Cancer: A 5-Year Update with a Focus on Breast and Lung Cancers.
循环 microRNAs 在癌症中的研究进展:以乳腺癌和肺癌为例的 5 年更新。
Int J Mol Sci. 2024 Mar 8;25(6):3140. doi: 10.3390/ijms25063140.